Photo

Photo detail

Illumina said it will continue to answer questions about its proposed acquisition of Pacific Biosciences ahead of a U.K. regulator's financial decision.

Stories this photo appears in:

Illumina’s $1.2 Billion Acquisition of Pacific Biosciences Tentatively Rejected

A U.K. antitrust regulator has tentatively rejected Illumina’s $1.2 billion acquisition of Pacific Bioscience with a final decision slated for December.

Tease photo